| scholarly article | Q13442814 |
| P2093 | author name string | Robert S Butler | |
| Anne C Cotleur | |||
| Clara M Pelfrey | |||
| Ioana R Moldovan | |||
| Natacha Zamor | |||
| P2860 | cites work | A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 |
| The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability | Q28284428 | ||
| Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis | Q33180102 | ||
| A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. | Q33882987 | ||
| Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. | Q35372676 | ||
| The increased susceptibility of women to multiple sclerosis | Q35473556 | ||
| Sex hormones modulate brain damage in multiple sclerosis: MRI evidence | Q35485697 | ||
| Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions | Q35819856 | ||
| Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis | Q36362874 | ||
| Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease | Q36364080 | ||
| Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis | Q36368128 | ||
| Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells | Q36380346 | ||
| Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection. | Q36890301 | ||
| Diversity and plasticity of self recognition during the development of multiple sclerosis | Q37365695 | ||
| A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota | Q37786871 | ||
| Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system | Q40796002 | ||
| IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. | Q41005196 | ||
| Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis | Q41092306 | ||
| Analysis of proteolipid protein (PLP)-specific T cells in multiple sclerosis: identification of PLP 95-116 as an HLA-DR2,w15-associated determinant | Q41275714 | ||
| T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. | Q41325764 | ||
| Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients | Q41332725 | ||
| Estrogen regulates the IFN-gamma promoter | Q41867280 | ||
| Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis | Q43876866 | ||
| Anti?tumor necrosis factor therapy abrogates autoimmune demyelination | Q43924367 | ||
| HLA determinants of susceptibility to multiple sclerosis in an Arabian Gulf population | Q44018063 | ||
| Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. | Q44070063 | ||
| Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients | Q44397694 | ||
| Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals | Q44894889 | ||
| Fine-specificity differences in the recognition of an encephalitogenic peptide by T helper 1 and 2 cells | Q46027709 | ||
| Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression | Q47635464 | ||
| Effect of gender on T-cell proliferative responses to myelin proteolipid protein antigens in patients with multiple sclerosis and controls | Q47666026 | ||
| 'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence. | Q48406670 | ||
| Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis | Q48851784 | ||
| Sex differences in proinflammatory cytokine profiles of progressive patients in multiple sclerosis. | Q51839122 | ||
| Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). | Q52519041 | ||
| A gender gap in autoimmunity. | Q55032884 | ||
| Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange | Q61709608 | ||
| Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? | Q67236213 | ||
| Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides | Q67692599 | ||
| Sex distribution, age of onset and HLA profiles in two types of multiple sclerosis. A role for sex hormones and microbial infections in the development of autoimmunity? | Q68809579 | ||
| Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro | Q70392550 | ||
| Identification of a second T cell epitope of human proteolipid protein (residues 89-106) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients | Q71642786 | ||
| Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis | Q72092884 | ||
| Identification of a novel T cell epitope of human proteolipid protein (residues 40-60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients | Q72092900 | ||
| Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization | Q72427037 | ||
| Both the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors | Q73703108 | ||
| Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions | Q73933738 | ||
| Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production | Q74027273 | ||
| In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis | Q74575052 | ||
| Sex differences in cytokine responses to myelin peptides in multiple sclerosis | Q74775389 | ||
| Plasma exchange for severe attacks of CNS demyelination: predictors of response | Q77462069 | ||
| IFNG polymorphisms are associated with gender differences in susceptibility to multiple sclerosis | Q81326731 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | sexual dimorphism | Q181497 |
| multiple sclerosis | Q8277 | ||
| P304 | page(s) | 161-169 | |
| P577 | publication date | 2007-11-26 | |
| P1433 | published in | Journal of Neuroimmunology | Q15716691 |
| P1476 | title | Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens | |
| P478 | volume | 193 |
| Q55357541 | Androgen-Induced Immunosuppression. |
| Q27012075 | Autoimmune T-cell reactivity to myelin proteolipids and glycolipids in multiple sclerosis |
| Q39287039 | Expanding Diversity and Common Goal of Regulatory T and B Cells. I: Origin, Phenotype, Mechanisms |
| Q51672793 | Gender-related differences in MS: a study of conventional and nonconventional MRI measures. |
| Q38517191 | Hormonal and gender-related immune changes in multiple sclerosis. |
| Q33533349 | Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population |
| Q86801307 | Lower serum levels of Th2-related chemokine CCL22 in women patients with multiple sclerosis: a comparison between patients and healthy women |
| Q34773444 | Memory B cells from a subset of treatment‐naïve relapsing‐remitting multiple sclerosis patients elicit CD4+ T‐cell proliferation and IFN‐γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein |
| Q91853720 | Parent-of-origin differences in DNA methylation of X chromosome genes in T lymphocytes |
| Q50146321 | Sex chromosome contributions to sex differences in multiple sclerosis susceptibility and progression |
| Q34498866 | Sex differences in autoimmune diseases |
| Q58563707 | Sex differences in autoimmune disorders of the central nervous system |
| Q91123514 | Sex differences in steroid levels and steroidogenesis in the nervous system: Physiopathological role |
| Q38471576 | Sex differences in the injured brain. |
| Q35619427 | Sex-related factors in multiple sclerosis susceptibility and progression |
| Q37518569 | Sex-specific therapeutic strategies based on neuroactive steroids: In search for innovative tools for neuroprotection. |
| Q92833943 | The effect of sex on multiple sclerosis risk and disease progression |
| Q39015338 | The importance of studying sex differences in disease: The example of multiple sclerosis |
Search more.